Hepatology (2014) 59:117497
For study participants treated with tirzepatide (5 mg, 10 mg and 15 mg, respectively), nausea (11.6 percent, 13.2 percent, 18.2 percent), diarrhea (11.6 percent, 14.0 percent, 11.6 percent), vomiting (3.3 percent, 2.5 percent, 5.8 percent) and constipation (5.8 percent, 5.0 percent, 6.6 percent) were more frequently experienced compared to placebo (6.1 percent [nausea], 7.8 percent [diarrhea], 1.7 percent [vomiting], 0.9 percent [constipation])
Ruhoy said on the Bendy Bodies podcast that she was not a big fan of supplements for most people
Urolithin C can alleviate the adverse effects of a choline-deficient amino acid-defined high-fat diet by regulating the AMPK-ferroptosis axis, which involves the gut-liver axis